Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1 https://www.biorxiv.org/content/10.1101/2023.07.23.550205v1?med=mas
Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1 https://www.biorxiv.org/content/10.1101/2023.07.23.550205v1?med=mas